SMMT
SUMMIT THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
SUMMIT THERAPEUTICS INC (SMMT) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$591.17M; the largest are Baker Bros. Advisors, Steven Cohen, Izzy Englander. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 1 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders52 also report options
Congress trades0
Price$16.39vs quarter-end+12.49%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew0
Added3
Trimmed / sold2
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Joel GreenblattHold
Value $229.1K0.0% of portfolio15,7272026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Joel Greenblatt | $229.1K | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $9.35M— of portfolio641,9002026 Q2
Value $7.39M— of portfolio507,5002026 Q2
Value $304.5K— of portfolio20,9002026 Q2
Value $246.2K— of portfolio16,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $9.35M | — | — |
| Ken GriffinPUT | $7.39M | — | — |
| Paul Tudor JonesCALL | $304.5K | — | — |
| Paul Tudor JonesPUT | $246.2K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.